Viewing Study NCT06780150


Ignite Creation Date: 2025-12-24 @ 5:20 PM
Ignite Modification Date: 2025-12-24 @ 5:20 PM
Study NCT ID: NCT06780150
Status: RECRUITING
Last Update Posted: 2025-11-21
First Post: 2025-01-13
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain (NfL) Levels and Participant Satisfaction in Participants With Multiple Sclerosis (MS)
Sponsor: Hoffmann-La Roche
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module